SuperworthIncannex Healthcare market cap IXHL
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $33.1M
- Highest close in our data
- $5.7B
- Nov 2022
Incannex Healthcare is worth $33.1M at the close on Oct 23, 2026, at $2.64 a share.
That is down 73% over the last year.
Its highest close in our data was $5.7B in Nov 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $33.1M | $33.1M | $137.1M | −76% |
| 2025 | $138M | $2M | $167.5M | +301% |
| 2024 | $34.4M | $24.4M | $1.7B | −98% |
| 2023 | $1.8B | $1.2B | $4.5B | −49% |
| 2022 | $3.6B | $3.5B | $5.7B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Incannex Healthcare's size, closest first, today.
| Company | Market cap |
|---|---|
| IXHLIncannex Healthcare | $33.1M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Incannex Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.